Mehrotra Parth 4
Research Summary
AI-generated summary
Privia Health (PRVA) CEO Parth Mehrotra Sells Shares
What Happened Parth Mehrotra, CEO of Privia Health Group, sold a total of 63,439 shares between March 6 and March 9, 2026 for an aggregate proceeds of approximately $1,456,240. Individual reported transactions:
- 21,440 shares on 2026-03-06 at $23.15 ($496,336)
- 21,915 shares on 2026-03-09 at a weighted $22.84 ($500,539)
- 1,219 shares on 2026-03-09 at a weighted $23.37 ($28,488)
- 18,865 shares on 2026-03-09 at a weighted $22.84 ($430,877)
These were sales (not purchases); sales are often routine (e.g., tax-withholding or pre-set plans) rather than an explicit bullish signal.
Key Details
- Dates/prices: Mar 6 (21,440 @ $23.15); Mar 9 (21,915 @ $22.84; 1,219 @ $23.37; 18,865 @ $22.84). Overall weighted avg ~ $22.95/share.
- Total shares sold: 63,439; total proceeds: ~$1,456,240.
- Shares owned after transaction: Not specified in the information provided.
- Footnotes: Some shares were sold to satisfy tax withholding on RSU vesting (sell-to-cover). Other sales were executed under a Rule 10b5-1 trading plan. Reported weighted-price ranges: $22.35–$23.34 and $23.35–$23.41; the filer can provide a full breakdown on request.
- Filing: Report filed March 10, 2026; timing appears consistent with normal Form 4 reporting windows.
Context These transactions include sell-to-cover activity related to restricted stock unit vesting and sales under a pre-established 10b5-1 plan. Such transactions are commonly administrative or tax-driven and do not necessarily reflect a change in the insider’s view of the company. If you want a full per-trade price breakdown or the insider’s post-sale holdings, the filer or the company can provide that information on request.
Loading document...